Your browser doesn't support javascript.
loading
Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.
Labbate, Craig V; Hensley, Patrick J; Miest, Tanner S; Qiao, Wei; Adibi, Mehrad; Shah, Amishi Y; Chery, Lisly; Papadopoulos, John; Siefker-Radtke, Arlene O; Gao, Jianjun; Guo, Charles C; Czerniak, Bogdan A; Navai, Neema; Kamat, Ashish M; Dinney, Colin P; Campbell, Matthew T; Matin, Surena F.
Afiliación
  • Labbate CV; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hensley PJ; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Miest TS; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Qiao W; Biostatistics and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Adibi M; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Shah AY; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Chery L; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Papadopoulos J; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Siefker-Radtke AO; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Gao J; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Guo CC; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Czerniak BA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Navai N; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kamat AM; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dinney CP; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Campbell MT; Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Matin SF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: surmatin@mdanderson.org.
Urol Oncol ; 40(10): 454.e17-454.e23, 2022 10.
Article en En | MEDLINE | ID: mdl-35961847
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ureterales / Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Urol Oncol Asunto de la revista: NEOPLASIAS / UROLOGIA Año: 2022 Tipo del documento: Article